Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonella typhimurium, and Pseudomonas aeruginosa
LEARN MOREFor the treatment of BRD in cattle, and the control of respiratory disease in cattle at high risk of developing BRD.
LEARN MORELearn more about this fast-acting pain relief solution for horses which is consistent, safe, and backed by Merck Animal Health.
LEARN MOREA powerful first-line, broad-spectrum topical medication administered twice a day for 7 days to treat otitis external in dogs.
LEARN MORE